Comparative Impact of RAST and TST for Improving Motor Functions in Stroke Patients

Comparative Impact of Rhythmic Auditory Stimulation Therapy and Task Specific Training for Improving Motor Functions in Stroke Patients

This study evaluates the effectiveness of Rhythmic Auditory Stimulation (RAS) therapy versus Task-Specific Training (TST) in enhancing motor function recovery in stroke patients. RAS uses rhythmic cues to aid movement synchronization, while TST focuses on practicing daily tasks to improve functional ability. In a randomized clinical trial, participants were assigned to either RAS or TST groups, with both receiving structured sessions over several weeks.

Study Overview

• Status: Active, not recruiting
• Conditions: Stroke
• Intervention / Treatment: Combination product: Rhythmic Auditory Stimulation Therapy; Combination product: Task-Specific Training

• Study Type: Interventional
• Enrollment (Actual): 40
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Pakistan
  • Punjab
    • Lahore, Punjab, Pakistan
      • Azra Naheed Medical College, Superior University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Male and female patients diagnosed with stroke
• Age 40-80 years (46)
• Patients having first ever stroke occurrence
• Moderate motor function impairments (47)
• Patients able to follow instruction

Exclusion Criteria:

• Patients with severe motor impairments
• Patients who had cognitive impairments
• Patients having other neurological conditions and musculoskeletal disorders
• Patients having history of surgery

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Rhythmic Auditory Stimulation Therapy	Combination product: Rhythmic Auditory Stimulation Therapy; Rhythmic auditory stimulation (RAS) is a therapeutic technique that uses rhythmic auditory cues, like a metronome or music, to improve motor control and coordination. It is often used in rehabilitation for conditions such as stroke, Parkinson's disease, and other movement disorders to enhance gait and other motor functions through the synchronization of movements to auditory rhythms.
Experimental: Task-Specific Training	Combination product: Task-Specific Training; Task-specific training is a rehabilitation approach that involves practicing specific tasks or activities to improve the performance of those tasks. It is based on the principle that repetitive practice of functional tasks enhances neuroplasticity, leading to better motor skills and functional recovery, especially in stroke and neurological rehabilitation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Modified Barthel index	The Modified Barthel Index (MBI) is a crucial tool for assessing functional independence in activities of daily living (ADLs) among patients, particularly those recovering from stroke or other debilitating conditions. It evaluates 10 key self-care and mobility tasks, including feeding, bathing, grooming, dressing, and mobility. Each task is scored based on the level of assistance required, with total scores ranging from 0 (complete dependence) to 100 (complete independence). Higher scores indicate greater independence.	12 Months
Goniometer	A goniometer is an instrument used to measure the angle of joints in the body, typically to assess the range of motion (ROM). It is commonly used in physical therapy, rehabilitation, and orthopedics to evaluate joint function and monitor progress in patients recovering from injury or surgery. Range of motions of upper limb measured through this goniometer."	12 Months

Collaborators and Investigators

• Sponsor: Superior University

Study record dates

Study Major Dates

• Study Start (Actual): February 15, 2024
• Primary Completion (Actual): July 1, 2024
• Study Completion (Estimated): March 1, 2025

Study Registration Dates

• First Submitted: December 26, 2024
• First Submitted That Met QC Criteria: January 5, 2025
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: January 5, 2025
• Last Verified: January 1, 2025

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases; Stroke
• Other Study ID Numbers: MSRSW/Batch-Fall22/760

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No